Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01383538
Title FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Andrew Ko
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field